These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 850907)

  • 61. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide.
    Cockell CS; Marshall JM; Dawson KM; Cederholm-Williams SA; Ponting CP
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):99-105. PubMed ID: 9639568
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Binding of alpha-2-antiplasmin with fibrinogen/fibrin and their fragments independent of factor XIII].
    Zadorozhna MB; Hrynenko TV; Iusova OI; Volkov HL
    Ukr Biokhim Zh (1999); 2004; 76(5):71-7. PubMed ID: 16100900
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.
    Harpel PC; Chang VT; Borth W
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10193-7. PubMed ID: 1438209
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Streptokinase activates plasminogen bound to human group C and G streptococci through M-like proteins.
    Ben Nasr A; Wistedt A; Ringdahl U; Sjöbring U
    Eur J Biochem; 1994 Jun; 222(2):267-76. PubMed ID: 8020466
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular biology of human plasminogen. I. Physiochemical properties and microheterogeneity.
    Collen D; de Maeyer L
    Thromb Diath Haemorrh; 1975 Nov; 34(2):396-402. PubMed ID: 806
    [No Abstract]   [Full Text] [Related]  

  • 67. Sites in fibrin involved in the acceleration of plasminogen activation by t-PA. Possible role of fibrin polymerisation.
    Nieuwenhuizen W
    Thromb Res; 1994 Aug; 75(3):343-7. PubMed ID: 7992246
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
    Nulkar MW; Pawse AR
    Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structural relationship between "glutamic acid" and "lysine" forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography.
    Wiman B; Wallén P
    Eur J Biochem; 1975 Jan; 50(3):489-94. PubMed ID: 122932
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preparation of plasminogen activator from vascular trees of human cadavers. Its comparison with urokinase.
    Aoki N
    J Biochem; 1974 Apr; 75(4):731-41. PubMed ID: 4847212
    [No Abstract]   [Full Text] [Related]  

  • 71. Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin.
    Tulinsky A; Park CH; Mao B; Llinás M
    Proteins; 1988; 3(2):85-96. PubMed ID: 3135547
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Studies on the lysine-binding sites of human plasminogen. The effect of ligand structure on the binding of lysine analogs to plasminogen.
    Winn ES; Hu SP; Hochschwender SM; Laursen RA
    Eur J Biochem; 1980 Mar; 104(2):579-86. PubMed ID: 6244956
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid.
    Sjöholm I
    Eur J Biochem; 1973 Nov; 39(2):471-9. PubMed ID: 4272770
    [No Abstract]   [Full Text] [Related]  

  • 74. The kringle 4 domain of chicken plasminogen.
    Gyenes M; Patthy L
    Biochim Biophys Acta; 1985 Dec; 832(3):326-30. PubMed ID: 4074753
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E; Rojas G
    Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Isolation of feline plasma plasminogen.
    Furukawa T; Sugiyama F
    Nihon Juigaku Zasshi; 1984 Dec; 46(6):867-70. PubMed ID: 6521146
    [No Abstract]   [Full Text] [Related]  

  • 77. Designing Smaller, Synthetic, Functional Mimetics of Sulfated Glycosaminoglycans as Allosteric Modulators of Coagulation Factors.
    Abdelfadiel EI; Gunta R; Villuri BK; Afosah DK; Sankaranarayanan NV; Desai UR
    J Med Chem; 2023 Apr; 66(7):4503-4531. PubMed ID: 37001055
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fibrinolytic Enzymes for Thrombolytic Therapy.
    Kumar SS; Sabu A
    Adv Exp Med Biol; 2019; 1148():345-381. PubMed ID: 31482506
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Site-selective protein conjugation at histidine.
    Peciak K; Laurine E; Tommasi R; Choi JW; Brocchini S
    Chem Sci; 2019 Jan; 10(2):427-439. PubMed ID: 30809337
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement.
    Gurewich V
    J Thromb Thrombolysis; 2015 Nov; 40(4):480-7. PubMed ID: 25894475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.